Neotame

• N-( N-(3,3 -dimethylbutyl) - L- α -aspartyl )-L- phenylalanine 1- methyl ester
• (all- S)-N -(N -(3,3- dimethylbutyl) - α -aspartyl ) phenylalanine 1- methyl ester
• E 961

Colorless crystalline powder

Fixed

80-83 ° C or 80.9 ° -83.4 C

Soluble in water, ethanol and ethyl acetate,

Template: Infobox chemical / molecular formula search available

Neotame is a sweetener that is synthesized from aspartame and 3,3 -dimethylbutyraldehyde. Its sweetening power is about 7000-13000 times stronger than that of sucrose. Furthermore, a taste-enhancing effect has been shown in various products. Neotame is stable when heated in a neutral pH range as aspartame. Neotame is in clinical trials no effect on blood sugar and insulin plasma concentrations and can therefore, under certain circumstances and subject to limited doses for dietetic and diabetic food can be used. Patients suffering from phenylketonuria, have also little to fear negative consequences, as neotame is used due to its high sweetening power only in very small amounts. Accordingly, the minimal amount of phenylalanine, which are released during the hydrolysis. This sweetener is approved in Australia and New Zealand since 2001, and in U.S. and Mexico. Since January 20, 2010 Neotame is also approved in the EU ( by policy 2009/163/EG ). The European Food Safety Authority (EFSA) has evaluated the safety of neotame and submitted to an advisory opinion. The EFSA concluded therein to the conclusion that neotame is safe as a sweetener and flavor enhancer in foods. As an acceptable daily intake (ADI ), the Authority shall establish 0-2 milligrams per kilogram of body weight per day. The sweetener carries the E number E 961